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Graphene oxide (GO) is increasingly used for controlling mass diffusion in
hydrogel-based drug delivery applications. On the macro-scale, the density
of GO in the hydrogel is a critical parameter for modulating drug release.
Here, we investigate the diffusion of a peptide drug through a network of
GO membranes and GO-embedded hydrogels, modelled as porous matrices
resembling both laminated and ‘house of cards’ structures. Our experiments
use a therapeutic peptide and show a tunable nonlinear dependence of the
peptide concentration upon time. We establish models using numerical simu-
lations with a diffusion equation accounting for the photo-thermal degradation
of fluorophores and an effective percolation model to simulate the experimen-
tal data. The modelling yields an interpretation of the control of drug diffusion
through GO membranes, which is extended to the diffusion of the peptide in
GO-embedded agarose hydrogels. Varying the density of micron-sized GO
flakes allows for fine control of the drug diffusion. We further show that
both GO density and size influence the drug release rate. The ability to tune
the density of hydrogel-like GO membranes to control drug release rates has
exciting implications to offer guidelines for tailoring drug release rates in
hydrogel-based therapeutic delivery applications.1. Introduction
Biocompatible graphene oxide (GO) is increasingly used in hydrogels to chemi-
cally immobilize therapeutic agents, or to modify mechanical and thermal
properties. GO can provide several therapeutic advantages such as the ability
to carry bioactive molecules into hydrogels [1], as well as providing structural
properties leading to increased drug-loading efficiency [2]. GO-embedded
hydrogels can potentially enhance the retardation of kidney filtration with a
corresponding increase in plasma half-life of therapeutic peptide and protein
drugs [3]. Clinical advantages include fewer injections for patients and reduced
side effects in patients.
GO is an oxidized form of graphene, which has a single-layer honeycomb
lattice of carbon atoms consisting of two interlocking triangular lattices, and
it has been extensively studied in various physical and chemical contexts
[4,5]. The chemical structure of GO consists of epoxide and hydroxyl species
in undefected carbon regions, while carboxyl, carbonyl and phenol groups
are found at the edges of the carbon sheets [6]. For this reason the GO structure
has been used to cross-link a variety of drugs for treating a variety of different
diseases [7,8]. GO has also been shown to be able to conjugate onto polymers,
rsif.royalsocietypublishing.org
J.R.Soc.Interface
15:20170949
2
 on March 6, 2018http://rsif.royalsocietypublishing.org/Downloaded from thus making them amenable to scaffold structures [9]. The
density of GO itself in a hydrogel can determine the rate of
release and provide sustained release of a therapeutic peptide
drug. Though initial studies showed that GO at high concen-
trations could have a dose-dependent toxicity due to the
activation of oxidative stress pathways [10], it has now been
shown, using in vitro and in vivo studies in a variety of cell
lines, that surface modification of GO using poly(acrylic
acid)-functionalization or PEGylation methods can render
GO structure biocompatible [8,11,12].
Water-soluble GO has also been used for controlling dif-
fusion of molecules through a hydrogel-like membrane. For
example, GO underpinned by diffusion and percolation
models has been studied for filtration applications of water
molecules [13]. It has also been described as a molecular
sieve allowing the permeation of ions of a certain hydrated
radius [14]. Moreover, GO was used in combination with
other composite materials to cross-link drugs to control
drug release within the network of hydrogels [15–17]. In
this model, it has been shown that the particle size of the
mobile phase has an effect on mass diffusion processes
within agarose gels, which involve electrostatic and other
interactions, as well as a percolation effect, within fractal
networks of pores [18]. Inspired by all these works, we inves-
tigate here, both theoretically and experimentally, a path
towards control and delay of drug release within GO
membranes and GO-embedded hydrogel networks.
One parameter that is rarely characterized is the density of
the GO in hydrogel-likematrices. This can be partly blamed on
the fact that suitable tools, including fluorescence recovery
after photobleaching (FRAP) [19] and fluorescence correlation
spectroscopy (FCS) [20], are sophisticated techniques requir-
ing specialized and expensive equipment or expertise for
data acquisition and analysis. We have side-stepped these
techniques by designing a novel, yet straightforward method
to measure mass diffusion based on the use of commercially
available microwell inserts. We apply an effective medium
approach providing crucial advantages over the other
diffusion techniques, including the requirement of a basic
laboratory plate reader and involving little post-experiment
data analysis. Additionally, the simple method that we
describe allows the simultaneous measurement of multiple
conditions where the number of samples is only limited by
the number of wells in the culture plate and microwell inserts.
Using this method, we study how the GO density in mem-
branes and hydrogel structures impedes the diffusion and
the rate of retardation of an anti-cancer peptide drug.
We augment our experimental studies, demonstrating the
control of the drug release properties of GO hydrogels, by
applying an effective (two-scale homogenization) model to
laminated and ‘house of cards’ configurations, to describe
the percolation of the model peptide in these structures
[21,22]. Using numerical stimulations, the density of GO in
hydrogels can be used as a parameter to predict and optimize
the rate of diffusion of the therapeutic peptide drug for con-
trolled release. Using principles of condensed matter theory
and effective medium approaches [23], one can fine-tune
the drug release properties of GO hydrogels by calculating
the overall GO composition (e.g. the laminated configuration
leads to stronger effective anisotropic diffusivity than ‘house
of cards’, and consequently to enhanced retardation effects).
Our modelling method also accounts for photobleaching in
the medium, which allows us to achieve a close fit betweenexperimental data and modelling estimates, providing more
accurate results for predicting the drug release rates under
various conditions.2. Methods
2.1. Peptide synthesis and diffusion experiments
The peptides used in this study were synthesized by GenScript
(Hong Kong, China), according to a previously reported amino
acid sequence (KLLLKLLKKLLKLLKKK, where bold characters
indicateD-amino acids) [24], with conjugation of fluorescein isothio-
cyanate (FITC) to theN-terminal of the peptide. A fluorescence plate
reader (FLUOstar Optima, BMG Labtech) (East Sussex, UK) was
used to carry out the mass diffusion measurements, using filter
sets appropriate for measuring FITC samples. GO in membranes
was represented as volume density (mg mm23). Cell culture mem-
brane inserts with a porosity of 0.4 mm were used to study the
diffusion rate of the fluorescently labelled peptide. The GO
(4 mg ml21 GO dispersion in water) (Sigma-Aldrich, France) was
used throughout (unless otherwise specified) and deposited onto
the membrane and dried by evaporation under exposure to high
heat.
GO-embedded hydrogels were prepared using standard
agarose (molecular biology grade) (Eurobio, France). An aqueous
solution containing 2.5 wt% agarose in 2ml of water is heated to
908C until a clear solution is obtained. A range of different
volumes of graphene suspension is added to the agarose solution
with stirring. A 0.1 ml aliquot of the resulting mixture is then
added in microwell inserts and the gels are allowed to solidify
for 1–2 h under ambient conditions.
Diffusion measurements are carried out using 0.6 ml of 0.1 M
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
buffer (pH 7.40) added to the lower wells of a microwell plate
and the fluorescent peptide (peptide-FITC, 0.33 mg ml21 in
0.1 M HEPES) is added into the insert. A fluorescent plate
reader is used to monitor the rate of drug diffusion by measuring
the accumulated fluorescence intensity–time course from the
lower chamber. The fluorescence measurement (bottom read) is
initiated immediately under ambient conditions and monitored
for several hours with a measurement cycle of 3 min. Each value
is representative of an averagemeasurement of 24 individual read-
ings taken from the circumference of each well of the plate. The
concentration of the peptide in each of the microwells is deter-
mined according to the measured fluorescence intensity using a
standard curve (electronic supplementary material, figure S1).3. Results and discussion
To experimentally investigate the effect of the GO density in
the membrane and hydrogel matrix on the rate of diffusion of
the drug molecule, we designed a simple set-up using a com-
mercially available microwell plate, coupled with Transwell
inserts and a plate reader. A previously characterized cationic
anti-cancer lytic peptide was used, whose mechanism of
action is based on the disintegration of the cell membrane,
leading to cell death. Incubation of human breast basal
epithelial cancer cells (MDA-MB-231) with different concen-
trations of the peptide showed previously a dose-dependent
reduction in cell proliferation [24]. Employing the FITC-
labelled peptide enables monitoring the presence of the
peptide in diffusion wells using the microwell plate reader
(electronic supplementary material, figure S1). To study the
diffusion rate of the fluorescently labelled peptide, we used
cell culture membrane inserts made of polyethylene
(T = t) (T = t + x)
transwell
fluorescent peptide
solution
hydrogel
transwell
lower well
measurements
averaged
n
GO fluorescentpeptide
(a) (b) (c)
(d) (e)
Figure 1. Experimental set-up for the measurement of the rate of diffusion of the fluorescent anti-cancer lytic peptide. (a) Schematic representation of graphene
oxide (GO) deposited onto the polyethylene terephthalate (PET) membrane. (b) A fluorescent peptide solution is added to the Transwell insert at the beginning of
the experiment (T ¼ t). (c) At increasing time points during the experiment (T ¼ t þ x), the concentration of fluorescent peptide in the lower culture well
chamber is measured. (d ) Image showing the Transwell insert with the GO membrane or GO-embedded agarose hydrogel deposited onto the PET membrane.
(e) Bottom-up measurements were taken using a fluorescence plate reader. A minimum of 24 individual fluorescence measurements were taken from the
entire circumference of the lower well for each time point for every condition of the experiment. An average of these measurements was calculated and plotted
for each time point. (Online version in colour.)
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deposited onto the top of the membrane. The rate of drug
diffusion was analysed by measuring the accumulated fluor-
escence signal (and equivalent peptide concentration) from
the lower chamber of the microwells (figure 1a,b,c and d,e).
Measurements carried out on different days using identical
sample conditions showed good reproducibility and repeat-
ability (electronic supplementary material, figure S2a–c).
This shows that the curves representing the concentration of
the released peptide in a function of time are the same for
the measurements carried out on different days. Linear
regression analysis showed that there is a linear positive
regression relationship between measurements carried out
on different days (r2 ¼ 0.9981), which was highly significant
( p-value , 0.0001), as calculated using the Prism v5.03 soft-
ware. Therefore, we show that our methodology has high
repeatability.
The diffusion curves of the peptide (figure 2 and elec-
tronic supplementary material, figure S3) indicate that the
magnitude of GO density in the membrane has a major
effect on the rate of mass transport. Depositing increasing
densities/quantities of GO in the membrane leads to a gra-
dual decrease in the time taken for the peptide to reach half
of its maximal intensity (t1/2). Therefore, the density of GO
in the membrane determines the rate of retardation of mass
transport. Increasing the GO membrane density retards,
and eventually halts, the rate of mass transport (see electronic
supplementary material, figure S3). In comparison to the
absence of GO in the membrane, including and increasing
the GO density to 0.03, 0.04, 0.08 and 0.4 mg mm23 retards
the peptide drug by five-, six-, sevenfold and completely,
respectively. This suggests that when the density of the GO
membrane is defined, it can be used as an important factor
in delaying release of a therapeutic agent. The reduction of
release rate of the therapeutic peptide upon increasing GOdensity hydrogels using this new method is reproducible
(electronic supplementary material, figure S4).
To test the effect of GO density in a therapeutic hydrogel
context, GO-doped hydrogel of agarose is used, with the con-
centration of fluorescent peptide kept constant. This shows
that the diffusion of the fluorescence peptide through the
gel barrier is significantly slower (figure 3 and electronic sup-
plementary material, figure S5) when compared with the
conditions without the hydrogel (figure 2), by approximately
half. Doping of GO with an average diameter of 1 mm into
the hydrogel at varying volume densities (0.4–2 mg mm23)
showed that a higher concentration of GO in the membrane
is able to implement more reductions in the rate of diffusion
of the therapeutic peptide. In particular, incorporating GO
into a hydrogel to a density of 2 mg mm23 results in the
complete retardation in peptide diffusion within the studied
period (13 h). The peptide that we used in our manuscript
was fully characterized by the company where it was
purchased. The peptide sequence is the following
KLfD-LgLKfD-LgLfD-LgfD-LgLLKfD-LgLKKKC with an
FITC modification occurring at the N-terminal. The peptide
was characterized to have a high HPLC purity (of more
than 95%) and a molecular weight measured by mass spec-
trometry analysis of 2667.51 Da (electronic supplementary
material, data 5). In a separate study, the data from Joshi
et al. [14] show that when a GO membrane is immersed in
an ionic solution, hydration increases the GO spacing to
approximately 0.9 nm. Unlike Joshi et al., we do not use
vacuum filtration for the preparation of the GO membrane.
However at higher GO membrane densities, when a more
homogeneous GO membrane is attained, peptide transport
does not occur and so our result is in good agreement with
what was found previously by Joshi et al. [14].
The same experiments were then carried out using GO
with a smaller average size (approx. 90 nm) (Nano Graphene
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Figure 3. Increasing the density of the GO in agarose hydrogels resulted in
the decrease of the diffusion rate of the anti-cancer lytic peptide. Different
densities of GO were embedded into a 2.5 wt%/vol agarose in translucent
cell culture inserts. The concentration of the fluorescent peptide in the
lower culture well chamber was measured and plotted against time.
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Figure 2. Varying the density of the GO membranes resulted in the change
of the rate of diffusion of the anti-cancer lytic peptide. GO dispersion in water
is prepared at different densities and dried onto translucent cell culture
inserts, with a porosity of 0.4 mm. The concentration of the fluorescent pep-
tide in the lower culture well chamber is measured and plotted against time.
The period of time indicated by the grey-shaded region corresponds to the
effect of photobleaching. (Online version in colour.)
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supermarket.com/) included into the hydrogel. High den-
sities of nanosized GO were able to reduce the rate of
diffusion of the peptide drug (electronic supplementary
material, figure S7). Compared to the absence of the GO
membrane, the time taken for half the maximum amount of
peptide to pass through the membrane is longer (111
versus 93 min, GO nanoparticle-containing hydrogel com-
pared to hydrogel alone). However, hydrogels containing
high densities of GO at the same time point release a third
less peptide drug (i.e. t1/2 ¼ 150 min). It should be noted
that lower densities of GO have much less effect on the diffu-
sion. Now that the predominant effect of GO density in GO-
doped hydrogels is clear, it is important to be able to interpret
the behaviour using numerical modelling in order to be able
to predict the effect of drug release retardation.
To be able to build predictive tools to analyse the behav-
iour of different densities of GO, it is important to gain more
information on the structural effects behind why GO density
is able to assert a retardation effect on the diffusion of a thera-
peutic peptide. For this, transmission electron microscopy
(TEM) is used to study the structural characteristics of GO
density. Low GO densities showed isolation of GO structures
(electronic supplementary material, figure S8a). However,
when the density of the GO in the membrane increases, the
TEM images show that the heterogeneous GO structures
have the tendency to aggregate, causing overlap of GO struc-
tures (electronic supplementary material, figure S8b). Upon
reaching a higher density of GO, complete overlap is
observed, which leads to superimposition of particles, as evi-
denced by an overall dark grey image, shown in electronic
supplementary material, figure S8c, thus highlighting the
accumulation effects of different concentrations of GO.
From the TEM images it can be noted that GO flakes share
similar features to clay including the heterogeneity in the
size, explaining the use of GO/clay composites [25]. GO
has a unique flake-like structure, thus able to act differently
when present in different densities. Increasing the density
of GO in membranes may alter the percolation of molecules
through an aggregated structure. In this study, we showed
that the density of GO in a membrane or hydrogel is animportant parameter in determining the rate of drug release.
The TEM experimental data of the GO showed that GO flakes
are well dispersed at low densities. However, at intermediate
densities, the GO flakes tend to stack together, thus leaving
empty regions in other areas. This is probably due to hydro-
gen bonding of water molecules in between the GO flakes.
The experimental techniques devised here to study the
effect of varying GO membrane density on the rate of diffu-
sion of the therapeutic peptide are the first description in
this context of a simple method to study the diffusion.
Additionally, multiple conditions can be simultaneously
measured using the set-up, allowing higher throughput
characterization of the drug diffusion. The data obtained
from the experimental analysis support the fact that the GO
density in the membrane can be used to vary the rate of dif-
fusion of therapeutic agents. The similar experiments using
GO-embedded hydrogels also showed that GO membranes
can provide prolonged drug release rates for the sustained
drug delivery of therapeutic agents.3.1. Using numerical modelling to predict drug release
by varying the density of graphene oxide
membranes
The numerical simulations presented in this study are the first
demonstration of the use of commercial finite element soft-
ware COMSOL Multiphysics (figures 4 and 5) for the
determination of the diffusion rate of a therapeutic peptide.
Our results show that we are able to clearly reproduce most
of the features of the experimental data (figures 2 and 3). In
this way, we are now able to predict the outcomes of drug
release from GOmembranes and GO hydrogels by considering
membranes and hydrogels of varying GO densities.
We applied an effective model for porous media to obtain
the numerical results (figures 4 and 5). The effective and ‘free’
diffusivities are usually related according to the equation
Deff ¼ D1/t, where 1 is the porosity of the structure and t
is the tortuosity, which is a measure of the actual length
per unit effective length a molecule has to diffuse in a
porous structure. Porosity of the modelled structure was cal-
culated by considering the ratio, we considered the ratio of
0.5
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Figure 4. Field maps of concentration from finite-element simulations for the effective diffusion rate. (a,b,d,e) A macroscopic cubical domain of side length 20 mm
with no flux boundary conditions on the left side, right side and at the bottom; an imposed concentration on the top and GO flakes (diffusivity 5500 cm2 s21) in a
water-based medium (diffusivity 1.5  1025 cm2 s21) overlying a porous polyethylene terephthalate (PET) membrane described by a slab 3 mm in thickness with
an effective anisotropic diffusivity Deff. Concentration of the peptide at time steps t ¼ 1 min (a,d ) and t ¼ 200 min (b,e). Peptide diffusion on low
(0.03 mg mm23) (a,b) and intermediate (0.08 mg mm23) (d,e) density of GO flakes (in units of ng mm23). Linear colour scale ranges from vanishing (dark
blue) to high (red) concentration normalized to 1. (c,f ) A microscopic cubical domain of typical side length h small compared to X (1 mm or less) with periodic
boundary conditions on opposite sides for low (c) and high ( f ) density of GO flakes displays periodic potentials W1 and W2 associated with effective anisotropy Deff.
Linear colour scale ranges from negative (dark blue) to positive (red) values of W1 and W2 normalized to 1. (Online version in colour.)
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Figure 5. Curves of the peptide concentration from finite-element simulations for the effective diffusion rate. (a) Diffusion model for photobleaching for figure 2: the
variation over time (min) of the peptide concentration (mM) for a density of GO of 0.01 mg mm23 observed experimentally (black line) is compared against
numerical simulations carried out using finite-element computations (grey line) for a diffusion model with effective parameters as given by equation (3.2).
The value of parameter aeff (alpha effective) in equation (3.2) is approximately 10
28 s21. Note that the values during 1–10 min were excluded from the
plot due to difficulties in matching the experimental and numerical curves. (b) Numerical simulations showing the variation in the concentration of the peptide
with time for low (0.05), intermediate (0.1) and high (0.5) densities of GO flakes (in units of mg mm23). (c) Diffusion model without photobleaching for figure 4:
same as (a) for GO in hydrogel. (d ) Numerical simulations showing the same as (b) for hydrogels with and without GO. Normalization was applied between
numerically computed and experimentally measured peptide concentrations at the initial time step in order to compare similar data. Diffusion coefficient for
the molecule is based on an agarose hydrogel [18]. (Online version in colour.)
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concentration then obeys Fick’s equation [26]:
1
@
@t
cðx1, x2, x3, tÞ  r:ðDeffðx1, x2, x3Þrcðx1, x2, x3, tÞÞ ¼ 0,
ð3:1Þ
where r ¼ ð@=@x1, @=@x2, @=@x3Þ denotes the gradient with
partial derivatives with respect to space variables xi. Tortuos-
ity is usually expressed as a power of the porosity [27],
therefore the effective diffusivity varies as Deff ¼ D1p.
We note that applying Fick’s equation simply leads to an
increase in diffusivity, reaching a plateau at longer time
points, which corresponds to the rate of diffusion of an anti-
cancer lytic peptide in GO hydrogels (figure 5c,d ), but does
not explain the relative decrease observed in concentration of
the same anti-cancer drug when it diffuses through a GO
membrane without hydrogel (figure 5a,b).
Our interpretation is that the physical system suffers
degradation due to photobleaching at longer time points.
We incorporated this factor of decay by using an additional
term: 0 , aeff  1 which is the rate of photobleaching
[28–30]:
@
@t
cr:ðDeffrcÞ þ aeffc ¼ 0: ð3:2Þ
We verified that the concentration versus time followed
the same trend in figure 2 and figure 5a for a value of par-
ameter aeff in equation (3.2), which is approximately
1028 s21. Regarding figure 3 and figure 5c,d, which display
a monotonically increasing solution to the diffusion equation,
the parameter aeff in equation (3.2) is zero, because no photo-
bleaching is observed. This can be attributed to the fact the
peptide is retarded in hydrogels and photobleaching effects
are only evident several hours after a plateau in intensity
has been reached; as the peptide in hydrogels took 13 h to
reach this maximal fluorescence intensity, the effects of
photobleaching cannot be measured.
In addition, this experimentally observed photobleaching
was incorporated into the numerical modelling. The effect of
photobleaching is evident in the experiments using micron-
sized GO membranes, which, unlike in membranes, have
higher peptide diffusion rates during the experimental time
points. Hydrogel experiments would have to be carried out
for much longer time periods for the effects of photobleaching
to be investigated in GO hydrogel. This shows that, after a
period of time, the peptide concentration decreases in GO
membranes (figure 2), unlike the monotonically increasing
concentration in GO hydrogels (figure 3). Photobleaching is
accounted for in figure 2 by adding an ad hoc term to the diffu-
sion equation (figure 5a–d), which is unnecessary for figure 4
as numerically checked in figure 5c,d, wherein the parameter
accounting for photobleaching is turned off. Therefore, we
are able to fit the experimental data to the modelling data in
both GO membranes and GO hydrogels. It should also be
noted that, in the course of our experimental study of GO
hydrogels, we observed that varying the density of nanosized
GO in hydrogels does not further delay the rate of diffusion of
an anti-cancer lytic peptide (electronic supplementary
material, figure S6), compared with GO hydrogels with the
same density of (micrometre-sized) GO (figure 3 and electronic
supplementary material, figure S3).
These experiments could be probably interpreted, as
described in [13], using an additional driving mechanismthat can be attributed to the interaction between monolayer
hydrogel (water in [6]) and the graphene walls similarly to
a theoretical experiment involving a 2D channel with a left
and a right reservoir and an effective capillary pressure P.
When the channel is fully filled, and an additional force is
applied to all oxygen atoms in the direction against the
flow, this mimics a gravitational force and can directly be
translated into an extra-capillary pressure P in the slit. It
was found that if P exceeded 500 bars [13], water molecules
in the channel were pulled back to the left reservoir, and the
2D capillary started to dry out. The value of P found in their
1 nm-sized slit is in qualitative agreement with the classical
estimates using the van der Waals interaction [31,32] between
water and graphite [13]. In the present work, the van der
Waals interaction would be an adverse effect to delayed
drug diffusion in hydrogels with nanosized particles.
However, equation (3.2) does not account for effective aniso-
tropic features that one would expect for a medium filled with
extremely elongated inclusions like GO flakes: indeed, the per-
colation behaviour of anisotropic particles can be subtle and
often counter-intuitive as noted in [33]. So we further compare
our effective model against a homogenized Fick’s equation
obtained from a two-scale asymptotic approach for a porous
medium consisting of a background with diffusivity D0 sur-
rounding inclusions that have high diffusivity Djh1 where
0 , h 1 and D0  Dj, j ¼ 1, . . . ,N. Note that this model
assumes certain periodicity in the medium, i.e. the set of
inclusions
SN
l¼1Vl should repeat periodically with periodicity
h in all three space dimensions, so we can define a periodic
cell hY ¼ ½0,h3. This means one considers a medium with a
large number of periodic cells themselves filled with a large
number of inclusions. For more details on this asymptotic
approach, which assumes two separate scales withmacroscopic
(so-called slow) variables ðx1, x2, x3Þ and microscopic (fast)
variables ðy1, y2, y3Þ ¼ ðx1=h, x2=h, x3=hÞ, one can find a vast
amount of literature, but the most relevant references are
[34,35]. Expanding the concentration as a Taylor series
cðx, tÞ ¼ c0ðx, x=h, tÞ þ hc1ðx, x=h, tÞ þ h2c2ðx, x=h, tÞ þ . . . and
rescaling the gradient asr ¼ rx þ h1ry, a hierarchyof partial
differential equations is obtained. By collecting terms, integrat-
ing quantities over the periodic cell, and invoking the
divergence theorem leads to (see also electronic supplementary
materials)
k1lY
@
@t
cr:ðDeffrcÞ ¼ 0 ð3:3Þ
and ½Deffkj ¼
ð
@Y
D0
@Wj
@yi
ðyÞ þ dij
 
yknids, ð3:4Þ
where kflY ¼
Ð
Y f ðyÞ dv and Y ¼ Y
SN
l¼1Vl is the volume
of the periodic cell Y excluding all inclusions and the
unknown functions Wj are solutions of annex problems on a
periodic cell Y*
@
@yi
D0
@Wj
@yi
ðyÞ þ dij
  
¼ 0, ð3:5Þ
with Wj ¼ yj on the boundary of each inclusion i.e. onSN
l¼1 @Vl and kW
jlY ¼ 0.
Solving the annex problem equation (3.5) for a periodic
cell shown in figure 4, which we take to be representative
of the GO membrane, we compute an effective diffusivity
according to equation (3.4) with diagonal entries
½Deff11 ¼ 0:5 105, ½Deff22 ¼ 25 105, ½Deff33 ¼ 25 105
and vanishing off-diagonal elements½Deffkj ≃ 1018,k,j ¼ 1,2,3.
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tory agreement with experimental results, so we once again
resorted to the percolation model, which now takes the form
(with effective anisotropy, porosity and tortuosity encapsu-
lated, with the values 1 ¼ 1/2 and p ¼ 3/2 assumed to be
reasonable from [27]):
1
@
@t
cr:ð1pDeffrcÞ þ aeffc ¼ 0: ð3:6Þ
For the sake of consistency (see electronic supplementary
material, figures S9 and S10), we compare this high-contrast
model with the numerical solution of the classical annex pro-
blem for a multiphase medium, where Y* is replaced by Y in
equation (3.3)–(3.5) and we now assume continuity of poten-
tial Wj and its flux ðDrWjÞ:n across the boundary of each
inclusion where n is the inward pointing unit normal onSN
l¼1 @Vl. Our numerical results lead to the same effective dif-
fusivity for the high-contrast and multiphase annex problems.
We further checked (see electronic supplementary material,
figure S11) that a ‘house of cards’ configuration for GO
flakes leads to an effective diffusivity with reduced anisotropy
in comparison with the laminated configuration, and conse-
quently less retardation in drug delivery. Finally, in the
course of the numerical simulations, we needed to calibrate
space and timescales with canonical examples of GO flakes
models (see electronic supplementary material, figure S12).
In conclusion to this modelling section, the experimental
data provided strong evidence to support our suggestion that
the density of the GO membrane can be used to modify the
rate of release of therapeutic drugs. Both laminated and ‘house
of cards’models are used tomodelGO in numerical and analyti-
cal simulations due to the resemblance of such assemblies to
those of GO structures. Our numerical investigations based on
the effective equation (3.6) demonstrate that the former, lami-
nated, configurations exhibit strong effective diffusivity that is
more conducive for diffusion delay. Importantly, the effective
model requires a large number of small (periodically assembled)
cells, but it does not give any more information regarding the
scaling (the small parameter h need only be small compared to
the typical dimensions of the polyethylene terephthalate (PET)
membrane, so we get the same effective diffusivity for nano-
and micrometre-sized GO flakes). Thus, in our opinion, we
cannot completely rule out a possible effect of van der Waals
forces for nanometre-sized GO flakes, because experiments
show a further diffusion delay in that case (which is not encap-
sulated by our homogenization model). Interestingly, it has
been previously shown that a homogenization approach of
Fick’s equation can be used to control processes of mass diffu-
sion for biological and engineering applications [36,37]. To
assess the fit of the model to the experimental data, the acquired
experimental data were compared with the effective mathemat-
ical models. The same equation as in [36] is used to retrieve in
(figure 5c,d) the main features of the experiments shown in
(figure 3). However, one notes that there is a decrease in the con-
centration after a certain time in (figure 2): this effect is the result
of photo-thermal degradation of fluorophores. To account for
this in the numerical modelling, a certain activation term aeff is
added in the diffusion equation (3.2) as described in the
methods, and as a result one gets figure 5a,b, which reproduces
the observed experimental effect.
It should be noted that the experimental set-up described
and used in figures 1–2 avoided evaporation of aqueous sol-
ution by using a parafilm coating of the upper and lowerchambers. Therefore, the dominant effects can be considered
to be associated with diffusion and photobleaching, whereas
convection and advection can be ruled out. The peptide mol-
ecule (the FITC part) is sensitive to photobleaching as shown
in electronic supplementary material, figure S9. This shows
that the fluorescent peptide which is exposed to light for
2 h results in a reduction of the overall fluorescence intensity
compared to the peptide protected from light and kept and
stored under the same conditions.
The results described in this manuscript have shown that
the micrometre-scale and nanometre-scale GO can be incorpor-
ated into hydrogels in order to provide sustained delivery of a
therapeutic peptide drug and thus avoid a ‘burst release’ of the
drug and improve drug efficacy. We believe that our results
show that the GO can have superior qualities over other 2D bio-
compatible materials such as bioceramics. Some of the
advantages over these materials are that it is easily available
in different forms (easier to fabricate), and it has higher tensile
strength and provides a tough biocompatible material, which
can be available at the micrometre and nanometre scale for
incorporation into biological scaffolds. Other types of scaffold-
ing materials such as polymer scaffolds can degrade in an
uneven manner [38], but GO does not have that issue. GO is
also available at a cheaper cost.4. Conclusion
Given that GO has great potential to be employed in biologi-
cal contexts such as hydrogel membranes, we demonstrate an
additional advantage to using GO in that the delayed drug
diffusion in GO membranes and hydrogels can be achieved
by controlling the GO density. Varying the density of GO
in the membranes means that the network structure becomes
less permeable to varying degrees. We used principles of an
effective percolation model to consider the movement of a
peptide drug in GO membranes. For optimization of the den-
sity of GO in the membrane to achieve the desired drug
diffusion rate, we employed numerical simulations which
included the experimental parameters such as physical move-
ment of the molecules and the photo-thermal degradation of
fluorophores. Therefore, this type of modelling will be useful
for contexts such as the prediction of the drug release proper-
ties of the hydrogels for therapeutic applications; this aids in
cutting down the amount of wet-lab materials required and,
by screening different criteria, this reduces the time taken for
experiments. In the context of hydrogels, it is evident that dif-
fusion rates of the peptide drug are significantly impeded
with the increased density of the doped GO. However, vary-
ing both the density and the size of the GO could be the key
to achieving the most efficient peptide release rates.
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